Welcome to our weekly Immunisation Update! In this week’s update read about:
GP alert: Abrysvo® vaccine administration errors
Annual immunisation update 2025 – recording now available
Measles alert – two confirmed cases
Measles vaccine QI activity
Beyfortus™ special order form
GP alert – Abrysvo® vaccine administration errors
NSW Health has received reports of Abrysvo® (RSV vaccine) incorrectly administered to children occurring in general practice. A NSW Health clinician alert was sent out to all GPs in NSW.
Key message:
Abrysvo® is licenced for use in pregnant women and adults aged 60 years and over. It is is NOT registered for use in children.
Beyfortus™ (nirsevimab) is registered for use in infants up to 24 months of age.
Arexvy® is only registered for use in adults aged 60 years and over.
Providers must clearly label RSV vaccines in fridge to prevent administration errors:
PRODUCT
LABEL WITH
Abrysvo (NIP-funded)
For use in pregnant women ONLY
Abrysvo (private) or Arexvy (private)
For with use in adults 60 years and over ONLY
Beyfortus (NSW-funded via special order)
Label with infant’s name upon receipt
To help prevent errors, refer to the new RSV immunisation product reference guide developed to assist providers, available on the NSW RSV Prevention Program – Information for health professionals webpage under the resources section.
Annual immunisation update 2025 – recording now available
Last week’s CESPHN annual immunisation update was attended by over 100 participants and provided crucial updates on several important topics. The webinar recording is now available for those who were unable to attend.
Key topics covered:
– New RSV immunisation products and recommendations
– Influenza and COVID-19 vaccine 2025 guidelines and recommendations
– Changes to the Australian Immunisation Register (AIR)
– Vaccines that are recommended but not funded
– Adolescent vaccination and funded catch-up programs
All immunisation providers must stay up-to-date with the latest 2025 immunisation information.
Measles alert – two confirmed cases
In the last week, NSW Health has been notified of two confirmed cases of measles. Both cases recently returned from South-East Asia (on different flights – Jetstar JQ62 and Vietnam Airlines VN773). There is an ongoing large outbreak of measles in several countries including Thailand, Vietnam, and Indonesia.
People who were on board the affected flights or attended any of the affected locations should watch for the development of symptoms. Several health facilities in CESPHN were affected, including Matraville Medical Complex, HealthSave Pharmacy Matraville,and Princes of Wales Hospital Emergency Department.
Measles vaccine (MMR) is available free to people who have not had 2 doses of MMR vaccine, born during or since 1966.
Conduct a measles quality improvement activity to recall patients who are not up to date with their measles vaccination. Book a QI session with a PHN support staff to get started, or follow the MMR QI guidelines.
Key message for immunisation providers:
– verify that all patients born after 1965 have received 2 doses of measles vaccine
– if vaccination history is unclear, additional MMR doses are safe
– MMR vaccination is particularly important prior to overseas travel
MMR vaccine is available from GPs for all ages and pharmacies for people aged 5 years and over.
This is because it is intended to be administered predominantly is a hospital setting prior to discharge to eligible newborns, under the NSW RSV Prevention Program.
Where an eligible infant has missed their hospital birth dose, general practices can place a Beyfortus™ special order for that individual. There is currently no option to bulk order Beyfortus™.
Special orders can also be placed for at-risk children up to 24 months of age entering their 2nd RSV season, and for vulnerable children born from 1 October 2024 to 16 March 2025 who meet the eligibility criteria for the NSW RSV Vulnerable Babies Program.
Triple protection: Vaccines for influenza, COVID-19 and RSV in 2025 Staying informed on the latest recommendations for vaccination is essential for immunisation providers as we approach the 2025 respiratory illness season. This NCIRS webinar will provide essential information that will support the delivery of government funded vaccines protecting against influenza, COVID-19 and RSV, as well as privately funded RSV vaccines for older adults, in 2025. The event will feature practical tips on delivery and maximising uptake for triple protection and an interactive live Q&A session.
Immunisation Weekly Update: School holidays – Immunisation checks prior to travel Global measles outbreak – Free catch-up MMR vaccines for everyone under 60 years Measles alert for Eastern Suburbs SKAI – discussing maternal RSV vaccination COVID-19 resources – New and updated AusVaxSafety’s 2025 flu vaccine surveillance begins Education In case…
Immunisation Weekly Update: Immunisation Weekly Update: Free MMR vaccine in NSW for travelling infants aged 6 to 12 months2025 NIP flu vaccine supply delaysNew AIR warning messages for RSV and flu vaccinesMandatory reporting changes to the AIR from 1 March 2025Parental barriers to childhood flu vaccinationNew data on RSV, flu,…
Immunisation Weekly Update: Welcome to our weekly Immunisation Update! In this week’s update read about: GP alert: Abrysvo® vaccine administration errors Annual immunisation update 2025 – recording now available Measles alert – two confirmed cases Measles vaccine QI activity Beyfortus™ special order form GP alert – Abrysvo® vaccine administration errors…